The expanding role of predictive toxicology: An update on the (Q) SAR models for mutagens and carcinogens

被引:84
作者
Benigni, Romualdo
Netzeva, Tatiana I.
Benfenati, Emilio
Bossa, Cecilia
Franke, Rainer
Helma, Christoph
Hulzebos, Etje
Marchant, Carol
Richard, Ann
Woo, Yin-Tak
Yang, Chihae
机构
[1] Ist Super Sanita, Dept Environm Hlth, I-00161 Rome, Italy
[2] Joint Res Ctr, European Commiss, Ispra, Italy
[3] Ist Ric Farmacol Mario Negri, Milan, Italy
[4] Consult Drug Design GbR, Wandlitz, Germany
[5] Silico Toxicol, Freiburg, Germany
[6] RIVM, Bilthoven, Netherlands
[7] Lhasa Ltd, Leeds, W Yorkshire, England
[8] US EPA, Natl Ctr Comp Toxicol, Res Triangle Pk, NC USA
[9] US EPA, Risk Assessment Div, Off Pollut Prevent & Toxics, Washington, DC USA
[10] Leadscope Inc, Columbus, OH USA
关键词
EU REACH legislation; OECD principles; (Q) SAR carcinogen mutagen;
D O I
10.1080/10590500701201828
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This article reflects the views of the authors as individual scientists and does not necessarily represent a position of the European Commission. Neither the European Commission nor any person acting on behalf of the Commission is responsible for the use that might be made of the presented information. This manuscript also does not necessarily reflect the views and policies of the US EPA, nor does mention of trade names or commercial products constitute endorsement or recommendation for use. Europe, increase the reliance on estimation methods for predicting potential chemical hazard. To meet the increased expectations, the availability of valid (Q)SARs becomes a critical issue, especially for endpoints that have complex mechanisms of action, are time- and cost-consuming, and require a large number of animals to test. Here, findings from the survey on (Q)SARs for mutagenicity and carcinogenicity, initiated by the European Chemicals Bureau (ECB) and carried out by the Istituto Superiore di Sanita' are summarized, key aspects are discussed, and a broader view towards future needs and perspectives is given.
引用
收藏
页码:53 / 97
页数:45
相关论文
共 66 条
[1]  
AMES BN, 1984, CANCER, V53, P2030
[2]  
Arcos Joseph C., 1995, P1
[3]   FUNDAMENTAL STRUCTURAL ALERTS TO POTENTIAL CARCINOGENICITY OR NONCARCINOGENICITY [J].
ASHBY, J .
ENVIRONMENTAL MUTAGENESIS, 1985, 7 (06) :919-921
[4]   CHEMICAL-STRUCTURE, SALMONELLA MUTAGENICITY AND EXTENT OF CARCINOGENICITY AS INDICATORS OF GENOTOXIC CARCINOGENESIS AMONG 222 CHEMICALS TESTED IN RODENTS BY THE UNITED-STATES NCI/NTP [J].
ASHBY, J ;
TENNANT, RW .
MUTATION RESEARCH, 1988, 204 (01) :17-115
[5]   NIH Molecular Libraries Initiative [J].
Austin, CP ;
Brady, LS ;
Insel, TR ;
Collins, FS .
SCIENCE, 2004, 306 (5699) :1138-1139
[6]   The use of structure-activity relationship analysis in the food contact notification program [J].
Bailey, AB ;
Chanderbhan, R ;
Collazo-Braier, N ;
Cheeseman, MA ;
Twaroski, ML .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2005, 42 (02) :225-235
[7]  
BENFENATI E, 2006, QUANTITATIVE STRUCTU
[8]   MOUSE BONE-MARROW MICRONUCLEUS ASSAY - RELATIONSHIPS WITH IN-VITRO MUTAGENICITY AND RODENT CARCINOGENICITY [J].
BENIGNI, R .
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH, 1995, 45 (03) :337-347
[9]   Structure-activity relationship studies of chemical mutagens and carcinogens: Mechanistic investigations and prediction approaches [J].
Benigni, R .
CHEMICAL REVIEWS, 2005, 105 (05) :1767-1800
[10]   Designing safer drugs: (Q)SAR-based identification of mutagens and carcinogens [J].
Benigni, R ;
Zito, R .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2003, 3 (11) :1289-1300